MANUFACTURERS LIFE INSURANCE COMPANY, THE - PROTEOSTASIS THERAPEUTICS IN ownership

PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 87 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q1 2019. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
MANUFACTURERS LIFE INSURANCE COMPANY, THE ownership history of PROTEOSTASIS THERAPEUTICS IN
ValueSharesWeighting
Q1 2019$13,000
-62.9%
10,423
-2.1%
0.00%
Q4 2018$35,000
+775.0%
10,650
+702.6%
0.00%
Q2 2018$4,000
-33.3%
1,3270.0%0.00%
Q1 2018$6,000
+100.0%
1,327
+83.8%
0.00%
Q2 2017$3,000
-40.0%
722
+16.1%
0.00%
Q1 2017$5,000
-37.5%
6220.0%0.00%
Q4 2016$8,000
-78.4%
622
-74.1%
0.00%
Q3 2016$37,000
+3600.0%
2,401
+2481.7%
0.00%
Q2 2016$1,000930.00%
Other shareholders
PROTEOSTASIS THERAPEUTICS IN shareholders Q1 2019
NameSharesValueWeighting ↓
VHCP Management III, LLC 848,610$2,749,0002.00%
GREAT POINT PARTNERS LLC 3,045,423$9,867,0001.25%
NEA Management Company, LLC 5,556,778$18,004,0000.71%
VHCP Management II, LLC 501,390$1,625,0000.70%
SECTORAL ASSET MANAGEMENT INC 1,581,728$5,125,0000.70%
HARBOURVEST PARTNERS LLC 440,627$1,428,0000.68%
EAM Investors, LLC 596,871$1,934,0000.52%
EAM Global Investors LLC 252,778$819,0000.45%
Avoro Capital Advisors LLC 1,300,000$4,212,0000.25%
Ghost Tree Capital, LLC 190,000$616,0000.22%
View complete list of PROTEOSTASIS THERAPEUTICS IN shareholders